This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Lactobacillus acidophilus
- DrugBank Accession Number
- DB15823
- Background
Not Available
- Type
- Biotech
- Groups
- Approved, Experimental
- Synonyms
- Acidophilus
- Bacillus acidophilus whole
- Bacterium acidophilum whole
- Lacteol
- Lactobacillus acidophilus
- Lactobacillus acidophilus whole
- Lactobacterium acidophilum whole
- Thermobacterium intestinale whole
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
- Contraindications & Blackbox Warnings
Avoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events & improve clinical decision support.- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Over the Counter Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Probiata Tablets Tablet 1 b Oral Purity Life Health Products A Division Of Sunopta Inc. 2001-09-01 2007-07-26 Canada 
- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Acidophilus Bifidum Bulgaricus Lactobacillus acidophilus (120 mg) + Bifidobacterium bifidum (120 mg) + Lactobacillus delbrueckii bulgaricus (120 mg) Capsule Oral Nutraceutical Corporation 2003-09-02 2006-08-02 Canada Gynoflor - Vaginaltabletten Lactobacillus acidophilus (50 mg) + Estriol (0.03 mg) Tablet Vaginal Gedeon Richter Plc 1990-02-09 Not applicable Austria 
GYNOFLOR 50 MG/0.03 MG VAJİNAL TABLET, 12 ADET Lactobacillus acidophilus (50 mg) + Estriol (0.03 mg) Suppository Vaginal ABDİ İBRAHİM İLAÇ SAN. VE TİC. A.Ş. 2020-08-14 Not applicable Turkey 
GYNOFLOR 50 MG/0.03 MG VAJİNAL TABLET, 6 ADET Lactobacillus acidophilus (50 mg) + Estriol (0.03 mg) Suppository Vaginal ABDİ İBRAHİM İLAÇ SAN. VE TİC. A.Ş. 2020-08-14 Not applicable Turkey ไกโนฟลอร์ Lactobacillus acidophilus (100000000 cfu) + Estriol (0.03 mg) Tablet Vaginal บริษัท ดีเคเอสเอช (ประเทศไทย) จำกัด 2011-09-16 Not applicable Thailand 
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 1PRR1V42V5
- CAS number
- 68333-16-4
References
- General References
- Not Available
- External Links
- 6205
- Wikipedia
- Lactobacillus_acidophilus
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 4 Completed Other Allergic Rhinitis (AR) 1 4 Completed Treatment Bacterial Vaginosis (BV) / Recurrences 1 4 Completed Treatment Diarrhoea Predominant Irritable Bowel Syndrome 1 4 Completed Treatment Probiotics / Type 1 Diabetes Mellitus 1 4 Not Yet Recruiting Treatment Chronic Sinusitis 1 4 Not Yet Recruiting Treatment Type 2 Diabetes Mellitus With Complication 1 4 Recruiting Treatment Bacterial Vaginosis (BV) 1 4 Recruiting Treatment Basal Ganglia Diseases / Brain Disorders / Central Nervous System Disorder / Diseases of the Nervous System / Motor Skills Disorders / Neurodegenerative Disorders / Parkinson's Disease (PD) / Parkinsonian Syndromes 1 4 Recruiting Treatment Colonoscopy / Constipation - Functional / Irritable Bowel Syndrome (IBS) / Probiotics 1 4 Recruiting Treatment Recurrent Vulvovaginal Candidiasis 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Tablet Vaginal Powder, for suspension Oral Capsule Oral 8000000000 [CFU]/1 Capsule Oral 16000000000 [CFU]/1 Tablet Vaginal 66.667 mg Suppository Vaginal Tablet Oral Capsule Oral 20000000000 [CFU]/1 Tablet Vaginal Tablet Oral 1 b Capsule Oral Capsule Oral 2 b / cap Capsule Oral 10000000000 [CFU]/1 - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at September 10, 2020 16:02 / Updated at September 13, 2020 19:13